169 related articles for article (PubMed ID: 36362174)
1. METCAM/MUC18 Plays a Tumor Suppressor Role in the Development of Nasopharyngeal Carcinoma Type I.
Liu YC; Chen YJ; Wu GJ
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362174
[TBL] [Abstract][Full Text] [Related]
2. METCAM/MUC18 augments migration, invasion, and tumorigenicity of human breast cancer SK-BR-3 cells.
Zeng G; Cai S; Liu Y; Wu GJ
Gene; 2012 Jan; 492(1):229-38. PubMed ID: 22057013
[TBL] [Abstract][Full Text] [Related]
3. Significance of expression of human METCAM/MUC18 in nasopharyngeal carcinomas and metastatic lesions.
Lin JC; Chiang CF; Wang SW; Wang WY; Kwan PC; Wu GJ
Asian Pac J Cancer Prev; 2014; 15(1):245-52. PubMed ID: 24528033
[TBL] [Abstract][Full Text] [Related]
4. METCAM/MUC18 is a novel tumor and metastasis suppressor for the human ovarian cancer SKOV3 cells.
Wu GJ; Zeng GF
BMC Cancer; 2016 Feb; 16():136. PubMed ID: 26906545
[TBL] [Abstract][Full Text] [Related]
5. METCAM/MUC18 promoted tumorigenesis of human breast cancer SK-BR-3 cells in a dosage-specific manner.
Huang CY; Wu GJ
Taiwan J Obstet Gynecol; 2016 Apr; 55(2):202-12. PubMed ID: 27125403
[TBL] [Abstract][Full Text] [Related]
6. Frequent and increased expression of human METCAM/MUC18 in cancer tissues and metastatic lesions is associated with the clinical progression of human ovarian carcinoma.
Wu GJ; Dickerson EB
Taiwan J Obstet Gynecol; 2014 Dec; 53(4):509-17. PubMed ID: 25510693
[TBL] [Abstract][Full Text] [Related]
7. Enforced Expression of METCAM/MUC18 Decreases In Vitro Motility and Invasiveness and Tumorigenesis and In Vivo Tumorigenesis of Human Ovarian Cancer BG-1 Cells.
Wu GJ
Adv Exp Med Biol; 2021; 1330():125-137. PubMed ID: 34339034
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of METCAM/MUC18 promotes motility, invasion, and tumorigenesis of human breast cancer cells.
Zeng GF; Cai SX; Wu GJ
BMC Cancer; 2011 Mar; 11():113. PubMed ID: 21450088
[TBL] [Abstract][Full Text] [Related]
9. Ectopic expression of MCAM/MUC18 increases in vitro motility and invasiveness, but decreases in vivo tumorigenesis and metastasis of a mouse melanoma K1735-9 subline in a syngeneic mouse model.
Wu GJ
Clin Exp Metastasis; 2016 Dec; 33(8):817-828. PubMed ID: 27510563
[TBL] [Abstract][Full Text] [Related]
10. METCAM/MUC18 Decreases the Malignant Propensity of Human Ovarian Carcinoma Cells.
Wu GJ
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30274262
[TBL] [Abstract][Full Text] [Related]
11. Anti-angiogenic pathway associations of the 3p21.3 mapped BLU gene in nasopharyngeal carcinoma.
Cheng Y; Ho RL; Chan KC; Kan R; Tung E; Lung HL; Yau WL; Cheung AK; Ko JM; Zhang ZF; Luo DZ; Feng ZB; Chen S; Guan XY; Kwong D; Stanbridge EJ; Lung ML
Oncogene; 2015 Aug; 34(32):4219-28. PubMed ID: 25347745
[TBL] [Abstract][Full Text] [Related]
12. CircZNF609 promotes cell proliferation, migration, invasion, and glycolysis in nasopharyngeal carcinoma through regulating HRAS via miR-338-3p.
Liu Z; Liu F; Wang F; Yang X; Guo W
Mol Cell Biochem; 2021 Jan; 476(1):175-186. PubMed ID: 32970285
[TBL] [Abstract][Full Text] [Related]
13. Interleukins, laminin and Epstein - Barr virus latent membrane protein 1 (EBV LMP1) promote metastatic phenotype in nasopharyngeal carcinoma.
Chew MM; Gan SY; Khoo AS; Tan EL
BMC Cancer; 2010 Oct; 10():574. PubMed ID: 20964870
[TBL] [Abstract][Full Text] [Related]
14. DLC-1, a candidate tumor suppressor gene, inhibits the proliferation, migration and tumorigenicity of human nasopharyngeal carcinoma cells.
Feng X; Li C; Liu W; Chen H; Zhou W; Wang L; Zhu B; Yao K; Jiang X; Ren C
Int J Oncol; 2013 Jun; 42(6):1973-84. PubMed ID: 23588806
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of p62 Induces Autophagy and Promotes Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma Cells through Promoting ERK Signaling Pathway.
Wu Q; Xiang M; Wang K; Chen Z; Long L; Tao Y; Liang Y; Yan Y; Xiao Z; Qiu S; Yi B
Curr Cancer Drug Targets; 2020; 20(8):624-637. PubMed ID: 32329689
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA ZFAS1 promotes tumorigenesis and metastasis in nasopharyngeal carcinoma by sponging miR-892b to up-regulate LPAR1 expression.
Peng J; Liu F; Zheng H; Wu Q; Liu S
J Cell Mol Med; 2020 Jan; 24(2):1437-1450. PubMed ID: 31851778
[TBL] [Abstract][Full Text] [Related]
17. GALNT7, a target of miR-494, participates in the oncogenesis of nasopharyngeal carcinoma.
Nie GH; Luo L; Duan HF; Li XQ; Yin MJ; Li Z; Zhang W
Tumour Biol; 2016 Apr; 37(4):4559-67. PubMed ID: 26503214
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.
Liang TS; Zheng YJ; Wang J; Zhao JY; Yang DK; Liu ZS
J Exp Clin Cancer Res; 2019 Feb; 38(1):97. PubMed ID: 30791932
[TBL] [Abstract][Full Text] [Related]
19. Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells.
Wu GJ; Peng Q; Fu P; Wang SW; Chiang CF; Dillehay DL; Wu MW
Gene; 2004 Mar; 327(2):201-13. PubMed ID: 14980717
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of long non-coding RNA TUG1 suppresses nasopharyngeal carcinoma progression by inhibiting epithelial-mesenchymal transition (EMT) via the promotion of miR-384.
Qian W; Ren Z; Lu X
Biochem Biophys Res Commun; 2019 Jan; 509(1):56-63. PubMed ID: 30581000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
